1987 Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 26: 2 (8574): 1483–1486, , , .
1996 Utility of the chemical use, abuse and dependence scale in screening patients with severe mental illness. Psychiatr Serv 47(6): 647–649, , , , .
2002 Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J 325: 1212–1213, , , , , .
2005 Psychosis in the community and in prisons: a report from the British National Survey of psychiatric morbidity. Am J Psychiatry 162(4): 774–780, , et al.
2003 Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatric Serv 54: 1395–1401, , , .
1998. Substance abuse in schizophrenia: a review. J Clin Psychiatry 3 [Suppl. 59]: 26–30
1994 Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. Am J Psychiatry 151(3): 385–389, , , .
1995 Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 23(4): 607–611, , , , .
2001 Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures. J Stud Alcohol 62(1): 79–88, , , .
2005 Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch of Gen Psychiatry 62(2): 137–145, , et al.
2004 Correlates of victimisation amongst people with psychosis. Soc Psychiatry Psychiatr Epidemiol 39 (10): 836–840, , , , , .
2004 The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud 41(3): 321–330, , , .
2004 Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry 65(2): 151–155, ,
2003 Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drugs Educ Prevent Policy Suppl 10: S1–S74, ,
2004 Stimulant psychosis: systematic review. Br J Psychiatry 185: 196–204, , .
2001 The association between psychosis and problematic drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 31: 659–668, .
2002 Cannabis and psychosis. Curr Psychiatry Rep 4(3): 191–196.
2003 Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Dep; 71(1): 37–48, , .
1996. Violence may be predicted among psychiatric patients. Br Med J 313: 318
2005 Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J Nerv Mental Disord 193(10): 673–679, , , .
2002 Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatr Serv 53(9): 1166–1170, , , , .
2005 Smoking behaviour in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Soc Sci Med 61(2): 293–303, .
2004 Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population. Schizophr Bull 30(4): 947–956, .
2004 Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. J Clini Psychiatry 65(3): 307–403, , et al.
2002 Psychosis and drug dependence: results form a national survey of prisoners. Br J Psychiatry 181: 393–398, , et al.
2006 Risk factors for experiencing psychosis during cocaine use: a preliminary report. J Psychiatr Res 40(2): 178–182, , , , .
2000 Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in patients with schizophrena. Am J Psychiatry 157(11): 1835–1842, , et al.
2003 Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophr Rese. 60: 81–85, , , , .
2004 First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res 1;66(2–3): 125–135, , et al.
2005 Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry 187: 306–313, ,
2003 Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18 month outcomes of a randomised control trial. Br J Psychiatry 183: 418–426, , et al.
1996 Psychiatric Research Interview for Substance and Mental disorders (PRISM): reliability for substance abusers. Am J Psychiatry 153: 1195–1201, ,
2001 Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics. J Stud Alcohol 62: 14–22, , .
2005 Drug screening among patients aged 17–40 admitted with psychosis. Tidsskr Nor Laegeforen 4;125(9): 1178–1180, , , .
2005 Prospective cohort study of cannabis use, predisposition for psychosis and psychotic symptoms in young people. Br Med J330(7481): 11, , et al.
2003 Comparing cannabis with tobacco. Br Med J 326: 942–943, , .
2005 Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care. Hum Psychopharmacol 20(3): 207–210, , .
2004 A group intervention which assists patients with dual diagnosis reduce their drug use; a randomized controlled trial. Psychol Med. 34(6): 983–990, , , , , .
2000 Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev. Issue 2. Art. No.: CD001088. DOI: 10. 1002/14651858. CD001088, , , .
2001 Psychiatric effects of cannabis. Br J Psychiatry 78: 116–122
2005 Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?J Psychopharmacol 19(3): 301–305, , , , , .
2002 Substance misuse in patients with schizophrenia, epidemiology and management. Drugs 65(5): 743–755, , ,
2004 Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res66(2–3): 115–124, , et al.
1994 Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51: 8–19, , et al.
1997 Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 23(2): 195–201, , , , , .
1996 A controlled study of education about drug treatment in schizophrenia. Br J Psychiatry 168: 709–717, , .
2004 Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res67(2–3): 157–166, , , , .
2002 Dual diagnosis motivational interviewing: a modification of Motivational Interviewing for substance-abusing patients with psychotic disorders. J Subst Abuse Treat 23: 297–308, , , , .
2004 The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 99: 39–52, .
2002 Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 181: 321–325
1995 A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. J Ner Men Dis 183: 762–767, , , .
1980 An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 168: 26–33, , , .
1992 The fifth edition of the addiction severity index. J Subs Abuse Treat 9 (3):199–213, , , et al.
1996 Drug and alcohol problems among individuals with severe mental illness in South London. Br J Psychiatry 168(5): 612–619, , et al.
2003 Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatr Serv 54: 554–561, , , , ,
2005 The Insight–Adherence–Abstinence triad: an integrated treatment focus for cannabis-using first-episode schizophrenia patients. Bull Meninger Clin 69(3): 220–230, , ,
2007 Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319–328, , et al.
2000 Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates and subgroups. Schizophr Bull 26(1): 179–192, , , , , .
1996 Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 46(8): 853–858, , , .
2005 Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Res 133(1): 35–43, , .
1995 Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models. Am J Psychiatry 152(10): 1450–1457, .
2000 Substance misuse, offending and mental illness: a review. J Psychiatr Ment Health Nurs 7: 483–489
Regier DA, Burke JD, Burke KC. 1990 Comorbidity of affective and anxiety disorders in the NIMH epidemiologic catchment area (ECA) program. In: , (eds) Comorbidity of Mood and Anxiety Disorders. Washington, DC; American Psychiatric Press
2002 Cannabis and mental health. Br Med J 325: 1183–1184, .
1997 Illness severity and treatment services for dually diagnosed severely mentally ill outpatients. Schizophr Bull 23(2): 239–246, .
1992 A model of integrated services for outpatient treatment of patients with comorbid schizophrenia and addictive disorders. Am J Addic 1(4): 339–348, , .
2004 Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci 29(6): 452–457, , .
Schools Health Education Unit. 2002 Young people in 2001. University of Exeter: School of Education
1997 The life-time rates of three major mood disorders and hour major anxiety disorders in alcoholics and controls. Addiction 92(10): 1289–1304, , et al.
1996 Opposite modulation of cocaine-seeking behaviour by D1- and D2-like dopamine receptor agonists. Science 271(5255): 1586–1589, , , .
2003 Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur Psychiatry 18: 133–136, , , , .
1996 Psychotic symptoms and disorders and the risk of violent behaviour in the community. Crim Behav Ment Health 6: 309–329, , , .
2004 Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 39 (1): 69–72, , .
2002 Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156(4): 319–327, , , , , .
1999 The effects of clozapine on aggression and substance abuse in schizophrenic patients. J Clin Psychiatry 60 [Suppl. 12]: 43–46
2006 Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophr Res 81(2–3): 145–150, , , , , .
1997 Pharmacotherapy of schizophrenia patients with comorbid substance abuse. Schizophr Bull 23(2): 215–228
2005 Hospital admissions for drug and alcohol use in people aged under 45. Br Med J 330: 115, , , .
2002 Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 325: 1199–1201, , , , .
1997 Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull 23(2): 229–238, .